Bora expands its CMDO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

by shannon | Oct 3, 2022 | News and Events

Bora establishes a lead position in Taiwan’s CDMO sector TAIWAN – Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of TWi Pharmaceutical Co.Ltd, a technology-based company...

Why it can take so long to validate pharmaceutical manufacturing processes during site-to-site technology transfers and what can be done to speed it up

by shannon | Sep 26, 2022 | Articles

Process validation too slow? Here’s how to speed things up Technology transfers and process validation are an integral part of drug development and commercial drug product manufacturing. Successful technology transfer from site-to-site requires careful evaluation of...

Supply chain disruptions and their impact on quality and operations

by shannon | Aug 2, 2022 | Articles

COVID-19’s impact on global supply chains as well as tectonic geopolitical shifts have resulted in considerable disruption, particularly to the contract development and manufacturing organization (CDMO) industry. Looking back, what is troubling about the supply chain...

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets

by shannon | May 10, 2022 | News and Events

Bora establishes a leadership position in Taiwan’s CDMO sector as it continues to expand into the global CDMO market Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the...

The legacy of Mississauga’s leadership in Environment, Health and Safety

by shannon | Apr 11, 2022 | Articles

As part of Bora Pharmaceuticals’ global growth strategy, the company successfully completed the acquisition of GSK’s Mississauga, Ontario (Canada) facility in 2020. Representing Bora’s first manufacturing facility in North America and its headquarters in the...